- Europe approves Biocon's Rosuvastatin Calcium tablets
- BENGALURU: Biotech major Biocon has received its first generic formulation approval in Europe, paving way for the company to launch Rosuvastatin Calcium tablets in several European countries. Biocon has received European approvals for Rosuvastatin ...
- EU approval for making Rosuvastatin a key milestone: Biocon
- A: The generic business, if you look at the size of the market today it genericises very fast.
- Merck Applauds the U.S. Department of Veterans Affairs (VA) for Broadening
- Healthcare professionals should not exceed atorvastatin 20mg/daily or rosuvastatin 10mg/daily when given with ZEPATIER.
- 지질 프로파일 개선 및 심혈관계 위험 감소에 있어 Rosuvastatin의 역할
- 심혈관질환을 예방하기 위해서는 LDL-C 수치를 낮게 유지하는 것이 중요한데 statin 제제가 1990년대 이후로 다양하게 개발되면서 지질 프로파일을 개선시키는 1차 약물로 널리 사용되고 있다.
- Impact of treatment with rosuvastatin and atorvastatin on cardiovascular
- Objective: No clinical trials have been conducted to directly compare the effect of the two high-intensity statins, rosuvastatin and atorvastatin, on cardiovascular outcomes.
Rosuvastatin is described in multiple online sources, as addition to our editors' articles, see section below for printable documents, Rosuvastatin books and related discussion.
Suggested News Resources
Related searchesthermic lance
dream symbol aurora borealis
schengen agreement uk and ireland
kanata ontario history
third millennium bce